Eugenio Miguel Santos de Dios-rekin lankidetzan egindako argitalpenak (10)

2023

  1. Characterization of mutant versions of the R-RAS2/TC21 GTPase found in tumors

    Oncogene, Vol. 42, Núm. 5, pp. 389-405

  2. Critical requirement of SOS1 for tumor development and microenvironment modulation in KRASG12D-driven lung adenocarcinoma

    Nature Communications, Vol. 14, Núm. 1

2022

  1. Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia

    Cancers, Vol. 14, Núm. 16

2021

  1. Anthraquinones as inhibitors of SOS RAS-GEF activity

    Biomolecules, Vol. 11, Núm. 8

  2. Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism, and redox homeostasis

    Oncogene, Vol. 40, Núm. 27, pp. 4538-4551

  3. Functional specificity of the members of the sos family of ras‐gef activators: Novel role of sos2 in control of epidermal stem cell homeostasis

    Cancers, Vol. 13, Núm. 9

  4. Sos2 comes to the fore: Differential functionalities in physiology and pathology

    International Journal of Molecular Sciences, Vol. 22, Núm. 12

2018

  1. Differential role of the RasGEFs Sos1 and Sos2 in mouse skin homeostasis and carcinogenesis

    Molecular and Cellular Biology, Vol. 38, Núm. 16

2017

  1. Ras-GRF2 regulates nestin-positive stem cell density and onset of differentiation during adult neurogenesis in the mouse dentate gyrus

    Molecular and Cellular Neuroscience, Vol. 85, pp. 127-147

2016

  1. Sos1 disruption impairs cellular proliferation and viability through an increase in mitochondrial oxidative stress in primary MEFs

    Oncogene, Vol. 35, Núm. 50, pp. 6389-6402